DMU Research Symposium
The Research Symposium aims to recognize the research efforts of those at Des Moines University (DMU) and in the surrounding medical and scientific community by providing a forum for the collaboration of ideas, the production of new hypotheses, and to demonstrate to the attendees the critical role that research plays in the advancement of health care.
DMU faculty, staff, students, residents, alumni, external researchers and health professionals from the Des Moines area and surrounding medical and scientific community are invited to participate and present. All students, faculty, and residents are encouraged to develop research projects to be presented at the Symposium.
Laurel L. Haak, PhD
Executive Director, ORCID
Dr. Haak is the executive director of ORCID, an international and interdisciplinary non-profit organization dedicated to providing the technical infrastructure to generate and maintain unique and persistent identifiers for researchers and scholars. She earned a BS and MS in Biology from Stanford University, completed her Ph.D. in neuroscience at Stanford University Medical School, and conducted postdoctoral research in neuronal-glial signaling at the National Institutes of Health.
Following postdoctoral work, she served as editor of Science Magazineâ€™s NextWave Postdoc Network, a weekly publication of the American Association for the Advancement of Science (AAAS). Dr. Haak was a program officer at the National Academies, where she directed workforce policy studies on international students, interdisciplinary research, women in academia, postdoctoral researchers, and innovation policy.
Prior to joining ORCID, Dr. Haak served as chief science officer at Discovery Logic, a Thomson Reuters business, where she led the Research Evaluation division.
Dr. Haak indicated she has no financial relationships to disclose relevant to the content of this CME activity.
|9 am||Poster Viewing|
Diversity, Databases, and Discoverability
|1:30 pm||Poster Session|
|2:30 pm||Oral Presentations (concurrent sessions)|
|3:45 pm||Poster Presentations|
|4:45 pm||Awards Presentation|
- Analyze the impact of the relationship between race, gender and ethnicity in the likelihood of receiving significant research funding.
- Use effective evaluation plans in reasech grants, particularly those that relate to training and development programs.
- Use tools to pro-actively improve the effectiveness of career tracking, evaluation efforts, and utilization of mentors.
- Discuss professional career tracking plans to improve the discoverability of researchers and clinicians in the scientific community.
No commercial interest provided financial support for this continuing education activity.
Continuing Education Credit
- MD: This activity has been planned and implemented in accordance with ACCME® Essential Areas and Elements and Iowa Medical Society (IMS) policies. Des Moines University is accredited by the IMS to provide continuing medical education for physicians. Des Moines University designates this live education activity for a maximum of 3.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- DO: Des Moines University (DMU) is accredited by the American Osteopathic Association and approves this live activity for 1.0 AOA Category 1-A CME credit(s), 1.0 AOA Category 2-A CME credit(s), and 1.5 AOA Category 2-B CME credit(s).
- Nurse: Des Moines University is Iowa Board of Nursing approved provider #112. This live activity has been reviewed and approved for 4.5 continuing education contact hour(s). No partial credit awarded.
- DPM: Des Moines University (DMU) is approved by the Council on Podiatric Medical Education as a sponsor of continuing education in podiatric medicine. DMU has approved this live activity for a maximum of 3.75 continuing education contact hour(s).
- Other: This live activity was designated for 3.75 AMA PRA Category 1 Credits™.
Everyone in a position to control the content of this educational activity will disclose to the CME provider and to attendees all relevant financial relationships with any commercial interest. They will also disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content for this program and the selection of speakers are responsibilities of the program director. Firms providing financial support did not have input in these areas.
- 3.75 AMA PRA Category 1 Credits™
- 1.00 AOA Category 1A
- 1.00 AOA Category 2A
- 1.50 AOA Category 2B
- 3.75 CE Contact Hour(s)
- 3.75 CPME
- 4.50 IBON